← FDA Drug Approvals (Drugs@FDA)

COPAXONE

NDA · New Drug Application · Sponsor: TEVA PHARMS USA · Approved 1996-12-20

Drug application

FDA Application #

NDA020622

Application type

New Drug Application

Brand name

COPAXONE

Generic name

GLATIRAMER ACETATE

Active ingredients

GLATIRAMER ACETATE

Dosage form

INJECTABLE

Route

SUBCUTANEOUS

Marketing status

Prescription

Sponsor

TEVA PHARMS USA

Manufacturer

Teva Neuroscience, Inc.

First approval

1996-12-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown